E-Mail
IMAGE: The experimental drug avasopasem manganese protects healthy tissue while enhancing radiation s capacity to kill cancerous tumor cells by converting superoxide to hydrogen peroxide. view more
Credit: Michael Story, Ph.D.
DALLAS - May 20, 2021 - An experimental drug that has shown promise in protecting healthy tissue from collateral damage caused by radiation therapy for cancer also appears to enhance radiation s capacity to kill tumors, a new study led by UT Southwestern scientists shows. The findings, published online in
Science Translational Medicine, could provide a much-needed boost to the radiation treatments used against a variety of tumor types.
The drug, avasopasem manganese (AVA), has already shown promise in clinical trials to prevent a side effect known as acute mucositis. This condition commonly occurs in head and neck cancer patients when radiation therapy damages mucous membranes. However, for this drug to become part of clinical care, it s
E-Mail
A small drug molecule that appears to protect normal tissue from the damaging effects of radiation, may simultaneously be able to boost the cancer-killing effect of radiation therapy, according to a new study led by scientists at University of Iowa, University of Texas Southwestern Medical Center, and Galera Therapeutics, Inc.
The study, published online May 12 in
Science Translational Medicine, suggests that the drug s dual effect is based on a fundamental difference between the ability of cancer cells and healthy cells to withstand the damaging effects of a highly reactive molecule called hydrogen peroxide, which is produced during the dismutation of superoxide.
Delhi Police joins hands with I2cure to fight Covid daijiworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daijiworld.com Daily Mail and Mail on Sunday newspapers.